These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8108488)

  • 1. Monte Carlo calculation of kerma to a point in the vicinity of media interfaces.
    Li Z; Williamson JF; Perera H
    Phys Med Biol; 1993 Dec; 38(12):1825-40. PubMed ID: 8108488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo evaluation of kerma at a point for photon transport problems.
    Williamson JF
    Med Phys; 1987; 14(4):567-76. PubMed ID: 3626996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical approach to heterogeneity correction factor calculation for brachytherapy.
    Daskalov GM; Kirov AS; Williamson JF
    Med Phys; 1998 May; 25(5):722-35. PubMed ID: 9608484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.
    Russell KR; Tedgren AK; Ahnesjö A
    Med Phys; 2005 Sep; 32(9):2739-52. PubMed ID: 16266087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
    Williamson JF; Perera H; Li Z; Lutz WR
    Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy.
    Valicenti RK; Kirov AS; Meigooni AS; Mishra V; Das RK; Williamson JF
    Med Phys; 1995 Jun; 22(6):821-9. PubMed ID: 7565373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-dimensional scatter-subtraction method for brachytherapy dose calculation near bounded heterogeneities.
    Williamson JF; Li Z; Wong JW
    Med Phys; 1993; 20(1):233-44. PubMed ID: 8455505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air.
    Rivard MJ; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2010 Feb; 37(2):869-76. PubMed ID: 20229896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
    Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
    Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1239-50. PubMed ID: 8985050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Monte Carlo photon transport simulation in characterizing brachytherapy dosimeter energy-response artefacts.
    Das RK; Li Z; Perera H; Williamson JF
    Phys Med Biol; 1996 Jun; 41(6):995-1006. PubMed ID: 8794480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigroup discrete ordinates modeling of 125I 6702 seed dose distributions using a broad energy-group cross section representation.
    Daskalov GM; Baker RS; Rogers DW; Williamson JF
    Med Phys; 2002 Feb; 29(2):113-24. PubMed ID: 11871380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV:EGS4 Monte Carlo model calculation.
    Luxton G; Jozsef G
    Med Phys; 1999 Dec; 26(12):2531-8. PubMed ID: 10619236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.